Medicamen Biotech Ltd posts strong results for Q1FY22

Medicamen Biotech Ltd. has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.27.60 crores during the period ended June 30, 2021 as compared to Rs.32.92 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.4.15 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.3.01 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.3.398 for the period ended June 30, 2021 as compared to Rs.2.467 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 27.60 crs	₹ 32.92 crs	-16.16%
Net Profit	₹ 4.15 crs	₹ 3.01 crs	37.87%
EPS	₹ 3.398	₹ 2.467	37.74%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.27.60 crores during the period ended June 30, 2021 as compared to Rs.27.86 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.4.15 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.2.24 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.3.398 for the period ended June 30, 2021 as compared to Rs.1.837 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 27.60 crs	₹ 27.86 crs	-0.93%
Net Profit	₹ 4.15 crs	₹ 2.24 crs	85.27%
EPS	₹ 3.398	₹ 1.837	84.98%

Shares of Medicamen Biotech Ltd. was last trading in BSE at Rs. 716 as compared to the previous close of Rs. 720.4. The total number of shares traded during the day was 10754 in over 245 trades.

The stock hit an intraday high of Rs. 740 and intraday low of 716. The net turnover during the day was Rs. 7842531.

Source : Equity Bulls

Keywords